Loading stock data…
ACH
$3.74+0.03 (+0.81%)
Market ClosedLast close May 1
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Accendra Health, Inc. in the Healthcare sector is trading at $3.74. The stock is currently 61% below its 52-week high of $9.55, remaining 0.5% below its 200-day moving average. Technical signals show neutral RSI of 66 and bullish MACD crossover, explaining why ACH maintains its current current market pressure. The Whystock Score of 30/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Overbought levels (RSI 66) — risk of consolidation or pullback
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$3.74
Potential Upside
5%
Whystock Fair Value$3.93
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, includi...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$264.48M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.26
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
260.95%
Volume
Today's trading volume
660,223
Recent News
Is the Options Market Predicting a Spike in Accendra Health Stock?
Investors need to pay close attention to Accendra Health stock based on the movements in the options market lately.
Accendra Health (ACH) Reports 2025 Revenue of $2.8B and Shift Toward Core Home-Based Care
Accendra Health Inc. (NYSE:ACH) is one of the most undervalued penny stocks to buy right now. On February 19, Accendra Health reported full-year 2025 revenue of nearly $2.8 billion, which was a 3% year-over-year increase. Despite this growth, Q4 adjusted EBITDA fell to $90 million from $102.5 million in the prior year, bringing the annual […]
Accendra Health Inc (ACH) Q4 2025 Earnings Call Highlights: Navigating Challenges and Strategic ...
Despite revenue growth and strategic divestitures, Accendra Health Inc (ACH) faces headwinds from payer loss and inflationary pressures while prioritizing debt reduction and technology investments.
Henry Schein Leadership Exit Tests Distribution Strength And Competitive Position
Henry Schein's former president of U.S. Distribution has left the company to become Chief Commercial Officer at Owens & Minor. The executive move involves a senior leader with decades of experience overseeing Henry Schein's U.S. distribution operations. The change raises questions for investors about continuity in Henry Schein's core distribution business and competitive positioning in healthcare supply. For investors watching Henry Schein (NasdaqGS:HSIC), this leadership change comes with...
Asian Equities Traded in the US as American Depositary Receipts Drop Sharply in Tuesday Trading
Asian equities traded in the US as American depositary receipts opened the shortened trading week sh